ESR2 and breast cancer: Given that MDA-MB-231 is the only BC cell line that expresses ERβ, but not ERα in the Western blot we conducted (Figure 1), the stronger response to DPN treatment in this cell line compared to the other BC cell lines might be attributed in part to the absence of ERα, which may counteract ERβ-mediated antiproliferative effects.